| Title |
Patient Barriers to and Enablers of Deprescribing: a Systematic Review
|
|---|---|
| Published in |
Drugs & Aging, August 2013
|
| DOI | 10.1007/s40266-013-0106-8 |
| Pubmed ID | |
| Authors |
Emily Reeve, Josephine To, Ivanka Hendrix, Sepehr Shakib, Michael S. Roberts, Michael D. Wiese |
| Abstract |
Inappropriate medication use is common in the elderly and the risks associated with their use are well known. The term deprescribing has been utilised to describe the complex process that is required for the safe and effective cessation of inappropriate medications. Given the primacy of the consumer in health care, their views must be central in the development of any deprescribing process. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 50% |
| Members of the public | 2 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 292 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 290 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 50 | 17% |
| Student > Ph. D. Student | 36 | 12% |
| Researcher | 35 | 12% |
| Student > Bachelor | 24 | 8% |
| Other | 20 | 7% |
| Other | 55 | 19% |
| Unknown | 72 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 98 | 34% |
| Pharmacology, Toxicology and Pharmaceutical Science | 53 | 18% |
| Nursing and Health Professions | 19 | 7% |
| Psychology | 10 | 3% |
| Social Sciences | 10 | 3% |
| Other | 22 | 8% |
| Unknown | 80 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2022.
All research outputs
#850,109
of 24,396,012 outputs
Outputs from Drugs & Aging
#23
of 1,281 outputs
Outputs of similar age
#7,117
of 203,000 outputs
Outputs of similar age from Drugs & Aging
#2
of 16 outputs
Altmetric has tracked 24,396,012 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,281 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,000 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.